WebJun 29, 2024 · Each SURPASS trial was designed to provide insights into tirzepatide’s potential as a treatment for type 2 diabetes. SURPASS-1 evaluated the efficacy and safety of three tirzepatide doses (5 mg, 10 … WebJun 29, 2024 · Tirzepatide is under development and in phase three of clinical trials for the treatment of type 2 diabetes. Each SURPASS trial was designed to provide insights into tirzepatide’s potential as a treatment for …
Landmark ACCORD Trial Finds Intensive Blood Pressure and …
WebThe NIDDK funded the landmark Diabetes Control and Complications Trial (DCCT) to see if people with type 1 diabetes who kept their blood glucose levels as close to normal as safely possible with intensive diabetes treatment (three or more shots of insulin per day or an insulin pump with self-monitoring of blood glucose at least four times per … WebJun 12, 2024 · In summary, the trial program showed that among patients with type 2 diabetes who had an increased risk of cardiovascular disease, patients treated with canagliflozin had a significantly lower ... iris assistance
Comparison of three meta-analytic methods using data from …
WebGeneral Description. Short-term studies have shown numerous benefits of weight loss in overweight or obese patients, including improvements in glycemic control, risk factors for cardiovascular disease, quality of life, and other obesity-related coexisting illnesses. The Look AHEAD study was designed to test whether weight loss similarly ... WebAug 27, 2024 · The results of this trial indicate that dapagliflozin is superior to placebo in improving HF outcomes among patients with symptomatic stable mildly reduced or preserved LVEF (EF >40%), irrespective of diabetes status and baseline NT-proBNP levels. Benefit is primarily driven by a reduction in HF hospitalizations, not mortality. WebFeb 28, 2024 · Clinical trials are part of clinical research and at the heart of all medical advances. Clinical trials look at new ways to prevent, detect, or treat disease. Scientists are conducting research to learn more about diabetes, including the following studies. The … iris asset manager